Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses

被引:1458
作者
Butte, Manish J.
Keir, Mary E.
Phamduy, Theresa B.
Sharpe, Arlene H. [1 ]
Freeman, Gordon J.
机构
[1] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[2] Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA
[3] Harvard Univ, Sch Med, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA
关键词
D O I
10.1016/j.immuni.2007.05.016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Pathways in the B7:CD28 family of costimulatory molecules regulate T cell activation and tolerance. B7-dependent responses in Cd28(-/-) Ctla4(-/-) T cells together with reports of stimulatory and inhibitory functions for Programmed Death-1 Ligand 1 or 2 molecules (PD-L1 or PD-L2) have suggested additional receptors for these 137 family members. We show that B7-1 and PD-L1 interacted with affinity intermediate to that of B7-1:CD28 and B7-1:CTLA-4. The PD-L1:B7-1 interface overlapped with the B7-1:CTLA-4 and PD-L1:PD-1 (Programmed Death-1) interfaces. T cell activation and cytokine production were inhibited by the interaction of B7-1 with PD-L1. The responses of PD-1 -deficient versus PD-1,B7-1 double-deficient T cells to PD-L1 and of CD28,CTLA-4 double-deficient versus CD28,CTLA-4,PD-L1 triple-deficient T cells to B7-1 demonstrated that PD-L1 and B7-1 interact specifically to inhibit T cell activation. Our findings point to a substantial bidirectional inhibitory interaction between B7-1 and PD-L1 and add an additional dimension to immunoregulatory functions of the B7:CD28 family.
引用
收藏
页码:111 / 122
页数:12
相关论文
共 53 条
  • [11] Dong HD, 2006, CELL MOL IMMUNOL, V3, P179
  • [12] Dong HD, 1999, NAT MED, V5, P1365
  • [13] Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730
  • [14] FREEMAN GJ, 1989, J IMMUNOL, V143, P2714
  • [15] Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
    Freeman, GJ
    Long, AJ
    Iwai, Y
    Bourque, K
    Chernova, T
    Nishimura, H
    Fitz, LJ
    Malenkovich, N
    Okazaki, T
    Byrne, MC
    Horton, HF
    Fouser, L
    Carter, L
    Ling, V
    Bowman, MR
    Carreno, BM
    Collins, M
    Wood, CR
    Honjo, T
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (07) : 1027 - 1034
  • [16] Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade
    Freeman, Gordon J.
    Wherry, E. John
    Ahmed, Rafi
    Sharpe, Arlene H.
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (10) : 2223 - 2227
  • [17] The B7 family revisited
    Greenwald, RJ
    Freeman, GJ
    Sharpe, AH
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2005, 23 : 515 - 548
  • [18] CTLA-4-Ig regulates tryptophan catabolism in vivo
    Grohmann, U
    Orabona, C
    Fallarino, F
    Vacca, C
    Calcinaro, F
    Falorni, A
    Candeloro, P
    Belladonna, ML
    Bianchi, R
    Fioretti, MC
    Puccetti, P
    [J]. NATURE IMMUNOLOGY, 2002, 3 (11) : 1097 - 1101
  • [19] Structure and dimerization of a soluble form of B7-1
    Ikemizu, S
    Gilbert, RJC
    Fennelly, JA
    Collins, AV
    Harlos, K
    Jones, EY
    Stuart, DI
    Davis, SJ
    [J]. IMMUNITY, 2000, 12 (01) : 51 - 60
  • [20] Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo
    Ito, T
    Ueno, T
    Clarkson, MR
    Yuan, XL
    Jurewiez, MM
    Yagita, H
    Azuma, M
    Sharpe, AH
    Auchincloss, H
    Sayegh, MH
    Najafian, N
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 174 (11) : 6648 - 6656